Skip to main content
SpringerLink
Log in

Clinical Pharmacology of Topical Steroids

  • Chapter
Pharmacology of the Skin II

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 87 / 2))

Abstract

The first report of the therapeutic use of topical hydrocortisone was published in 1952 by Sultzberger and Witten and many more potent synthetic steroids have been developed since. Ideally the pharmacological actions of topically applied steroids would be limited to the skin without systemic local adverse effects. Although this has not been achieved, there have been considerable advances both in potency of steroids available for clinical use and in the understanding of their pharmacological effects on the skin. Glucocorticoids are widely used in the treatment of skin disorders, but their specific indications are outside the scope of this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Akers WA (1980) Risks of unoccluded topical steroids in clinical trials. Arch Dermatol 116:786–788

    Article  PubMed  CAS  Google Scholar 

  • Anonymous (1977) The hazardous jungle of topical steroids. Lancet 2:487–488

    Google Scholar 

  • Anonymous (1980) Perioral dermatitis. Lancet 1:75–76

    Google Scholar 

  • Baker H (1976) Corticosteroids and pustulae psoriasis. Br J Dermatol [Suppl 12]94:83–88

    Article  PubMed  Google Scholar 

  • Barry BW, Woodford R (1977) Vasoconstrictor activities and bioavailabilities of seven proprietary corticosteroid creams assessed using a non-occluded multiple dosage regimen: clinical implications. Br J Dermatol 97:555–560

    Article  PubMed  CAS  Google Scholar 

  • Black MM, Shuster S, Bottoms EJ (1973) Skin collagen and thickness in Cushing’s syndrome. Arch Dermatol Forsch 246:365–368

    Article  PubMed  CAS  Google Scholar 

  • Braathen LR, Hirschberg H (1984) The effect of short-term corticosteroids incubation on the alloactivating and antigen-presenting capacity of human epidermal Langerhans cells. Br J Dermatol 111:295–302

    Article  PubMed  CAS  Google Scholar 

  • Bray MA, Gordon D (1978) Prostaglandin production by macrophages and the effect of anti-inflammatory drugs. Br J Clin Pharmacol 63:635–642

    CAS  Google Scholar 

  • Briggs MM, Briggs M (1973) Induction by topical corticosteroids of skin enzymes metabolising carcinogenic hydrocarbons. Br J Dermatol 88:75–81

    Article  PubMed  CAS  Google Scholar 

  • Bronstein SW, Bickers DR, Lamkin BC (1984) Bullous dermatosis caused by Staphylococcus aureus in locus minosis resistantiae. J Am Acad Dermatol 10:259–263

    Article  PubMed  CAS  Google Scholar 

  • Burdick KH, Haleblian JK, Poulsen BJ, Cobner SE (1973) Corticosteroid ointments: comparison by two human bioassays. Curr Ther Res 15:233–242

    PubMed  CAS  Google Scholar 

  • Burton JL, Cunliffe WJ, Holti G, Wright V (1974) Complications to topical steroids in patients with liver disease. Br J Dermatol [Suppl 10]92:22–23

    Article  Google Scholar 

  • Delforno C, Holt PJA, Marks R (1978) Corticosteroid effect on epidermal cell size. Br J Dermatol 98:619–623

    Article  PubMed  CAS  Google Scholar 

  • Durant S, Duval D, Homo-Delarche F (1986) Factors involved in the control of fibroblast proliferation by glucocorticoids: a review. Endocr Rev 7:254–269

    Article  PubMed  CAS  Google Scholar 

  • Du Vivier A, Stoughton RB (1975) Tachyphylaxis to the action of topically applied steroids. Arch Dermatol 3:581–583

    Article  Google Scholar 

  • Dykes J, Marks R (1979) An appraisal of the methods used in the assessment of atrophy from topical corticosteroids. Br J Dermatol 101:599–609

    Article  PubMed  CAS  Google Scholar 

  • Epstein EH, Bonifas JM (1982) Glucocorticoid receptors of normal human epidermis. J Invest Dermatol 78:144–146

    Article  PubMed  CAS  Google Scholar 

  • Epstein EH, Munderloh NH (1981) Glucocorticoid receptors of mouse epidermis and dermis. Endocrinology 108:703–711

    Article  PubMed  CAS  Google Scholar 

  • Evans CD, Harman RRM, Warin RP (1967) Varicose ulcers and use of topical corticosteroids. Br Med J 4:482

    Article  Google Scholar 

  • Finnen MJ, Herdman ML, Shuster S (1984) Induction of drug metabolising enzymes in the skin by topical steroids. J Steroid Biochem 20:1169–1173

    Article  PubMed  CAS  Google Scholar 

  • Fisher AA (1983) Topical adrenal steroids and patch tests. Arch Dermatol 119:956

    Article  PubMed  CAS  Google Scholar 

  • Fritz KA, Weston WL (1983) Topical glucocorticosteroids. Ann Allergy 50:68–76

    PubMed  CAS  Google Scholar 

  • Gibson JR, Kirsch JM, Darley CR, Harvey SG, Burke CA, Hanson ME (1984) An assessment of the relationship between vasoconstrictor assay findings, clinical efficacy and skin thinning effects of a variety of undiluted and diluted corticosteroiod preparations. Br J Dermatol [Suppl 27]3:204–212

    Article  Google Scholar 

  • Halliday GM, Knight BA, Muller HK (1986) Reduction of murine Langerhans cell ATPase staining following topical, but not systemic treatment with steroid and non-steroid immunosuppressants. Br J Dermatol 114:83–89

    Article  PubMed  CAS  Google Scholar 

  • Horrobin DF, Mtabaji JP, Manku MS (1976) Physiological Cortisol levels block the inhibition of vascular reactivity produced by prolcatin. Endocrinology 99:406–410

    Article  PubMed  CAS  Google Scholar 

  • Ive FA, Marks R (1968) Tinea incognita. Br Med J 3:149–152

    Article  PubMed  CAS  Google Scholar 

  • Johns AM, Bower BD (1970) Wasting of the napkin area after repeated use of fluorinated steroid ointments. Br Med J 1:347–348

    Article  PubMed  CAS  Google Scholar 

  • Johnson LK, Longenecker JP, Baxter JD, Dallman MF, Widmaier EP, Eberhardt NL (1982) Glucocorticoid action: a mechanism involving nuclear and non-nuclear pathways. Br J Dermatol [Suppl 23]107:6–23

    Article  PubMed  CAS  Google Scholar 

  • Kirsch J, Gibson JR, Darley CR, Barth J, Burke CA (1982) Forearm site variation with the corticosteroid vasoconstrictor assay. Br J Dermatol 106:495

    Article  PubMed  CAS  Google Scholar 

  • Kligman AM, Willis I (1975) A new formula for depigmenting human skin. Arch Dermatol 111:40–48

    Article  PubMed  CAS  Google Scholar 

  • Lavker RM, Schechter NM, Lazarus GS (1986) Effects of topical corticosteroids on human dermis. Br J Dermatol [Suppl 31]115:101–107

    Article  PubMed  Google Scholar 

  • Leiferman KM, Schroeter A, Kirschner MK, Speisberg TG (1983) Characterisation of the glucocorticoid receptor in human skin. J Invest Dermatol 81:355–360

    Article  PubMed  CAS  Google Scholar 

  • Maibach HI (1976) In vivo percutaneous penetration of corticoids in man and unresolved problems in their efficacy. Dermatologica [Suppl 1]152:11–25

    Article  PubMed  CAS  Google Scholar 

  • Malkinson FD (1958) Studies on the percutaneous absorption of C14 labelled steroids by use of the gas flow cell. J Invest Dermatol 31:19–26

    PubMed  CAS  Google Scholar 

  • Malkinson FD, Lee MW, Cutukovic I (1959) In vitro studies of adrenal steroid metabolism in the skin. J Invest Dermatol 32:101–108

    Article  PubMed  CAS  Google Scholar 

  • Martindale (1982) The extra pharmacopoeia, 28th edn. Pharmaceutical Press, London

    Google Scholar 

  • Miller JA, Munro DD (1980) Topical corticosteroids: clinical pharmacology and therapeutic use. Drugs 19:119–134

    Article  PubMed  CAS  Google Scholar 

  • Munro DD (1976) The effect of percutaneously absorbed steroids in hypothalamic-pituitary-adrenal function after intensive use in inpatients. Br J Dermatol [Suppl 12]94:67–76

    Article  PubMed  Google Scholar 

  • Munro DD, Clift DC (1973) Pituitary-adrenal function after prolonged use of topical corticosteroids. Br J Dermatol 88:381–385

    Article  PubMed  CAS  Google Scholar 

  • Norris JFB, Iderton E, Yardley HJ, Summerly K, Forster S (1984) Utilisation of epidermal phospholipase A2 inhibtion to monitor topical steroid action. Br J Dermatol [Suppl 27]3:195–203

    Article  Google Scholar 

  • Pannatier A, Jenner P, Testa B, Etter JC (1978) The skin as a drug-metabolising organ. Drug Metab Rev 8:319–343

    Article  PubMed  CAS  Google Scholar 

  • Ponec M, Kempenaar SA, van der Meulen-van Harskamp GA, Bachra BN (1979) Effects of glucocorticoids on cultured human skin fibroblasts. IV. Specific decrease in synthesis of collagen but no effect on its hydroxylation. Biochem Pharmacol 28:2777–2783

    Article  PubMed  CAS  Google Scholar 

  • Ponec M, Derkloet ER, Kempenaar JA (1980) Corticoids and human skin fibroblasts: intracellular specific binding in relation to growth inhibition. J Invest Dermatol 75:293–296

    Article  PubMed  CAS  Google Scholar 

  • Rawlins MD, Shaw V, Shuster S (1979) The in vitro metabolism of betamethasone-17-valerate by human skin. Br J Pharmacol 66:441 P

    Google Scholar 

  • Reddy BSN, Singh G (1976) A new model for human bioassay of topical corticosteroids. Br J Dermatol 94:191–193

    Article  PubMed  CAS  Google Scholar 

  • Rongone EL (1977) Cutaneous metabolism P 93–137. In: Marzulli FM, Maibach HI (eds) Dermatotoxicology and pharmacology. Wiley and Sons, New York (Advances in modern toxicology, vol 4)

    Google Scholar 

  • Saarni H, Jalkanen M, Hopsu-Havu VK (1980) Effect of five anti-inflammatory steroids on collagen and glycoaminoglycan synthesis in vitro. Br J Dermatol 103:167–173

    Article  PubMed  CAS  Google Scholar 

  • Scarborough H, Shuster S (1960) Corticosteroid purpura. Lancet 1:93–94

    Article  PubMed  CAS  Google Scholar 

  • Shuster S (1979) The cause of striae distensae. Acta Derm Venereol (Stockh) [Suppl 89]59:161–169

    CAS  Google Scholar 

  • Shuster S (1985) OTC sale of topical corticosteroids. Br Med J 2:967–968

    Article  Google Scholar 

  • Shuster S, Raffle EJ, Bottoms EJ (1967) Skin collagen in rheumatoid arthritis and the effects of corticosteroids. Lancet 1:525–527

    Article  Google Scholar 

  • Smith K, Shuster S (1984 a) Characterisation and quantification of epidermal and dermal glucocorticoid receptors in the rat. J Invest Dermatol 82:44–48

    Article  PubMed  CAS  Google Scholar 

  • Smith K, Shuster S (1984 b) Effect of adrenalectomy and steroid treatment on rat skin cy-tosol glucocorticoid receptor. J Endocrinol 102:161–165

    Article  PubMed  CAS  Google Scholar 

  • Smith K, Shuster S, Rawlins M (1983 a) Characterisation of the glucocorticoid receptor in rat skin. J Endocrinol 96:229–239

    Article  PubMed  CAS  Google Scholar 

  • Smith K, Shuster S, Walton S, Rawlins MD (1983 b) Characterisation of the glucocorticoid receptor in human skin. Br J Dermatol 109:222–223

    Article  Google Scholar 

  • Stahle M, Hagermark D (1984) Effects of topically applied clobetasol-17-propionate on histamine release in human skin. Acta Derm Venereol (Stockh) 64:239–642

    CAS  Google Scholar 

  • Sulzberger MB, Witten VH (1952) The effect of topically applied compound E in selected dermatoses. J Invest Dermatol 191:101–102

    Google Scholar 

  • Vickers CFH (1963) Existence of reservoir in the stratum corneum. Arch Dermatol 88:20–23

    Article  PubMed  CAS  Google Scholar 

  • West DP, Worobec S, Solomon LM (1981) Pharmacology and toxicology of infant skin. J Invest Dermatol 76:147–150

    Article  PubMed  CAS  Google Scholar 

  • Whitefield M (1977) Topical steroids. Lancet 2:925

    Article  Google Scholar 

  • Wilkinson DS, Kirton V, Wilkinson JD (1979) Perioral dermatitis: a 12 year review. Br J Dermatol 101:245–257

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. D. N. Bateman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Institute of Dermatology, St. Thomas’s Hospital, Lambeth Palace Road, SE1 7EH, London, Great Britain

    Malcolm W. Greaves M.D., Ph.D., F.R.C.P.

  2. Department of Dermatology, The Royal Victoria Infirmary, The University of Newcastle upon Tyne, NE1 4LP, Newcastle upon Tyne, Great Britain

    Sam Shuster M.D., Ph. D., F.R.C.P.

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Bateman, D.N. (1989). Clinical Pharmacology of Topical Steroids. In: Greaves, M.W., Shuster, S. (eds) Pharmacology of the Skin II. Handbook of Experimental Pharmacology, vol 87 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74054-1_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-74054-1_19

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-74056-5

  • Online ISBN: 978-3-642-74054-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation